Skip to main content
Erschienen in: Cancer Causes & Control 7/2015

01.07.2015 | Brief report

Sleep duration and cancer risk in women

verfasst von: Susan Hurley, Debbie Goldberg, Leslie Bernstein, Peggy Reynolds

Erschienen in: Cancer Causes & Control | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective was to conduct an analysis of sleep duration and risk of selected site-specific and groups of cancer among a large prospective cohort of California women.

Methods

The study population was comprised of 101,609 adult females participating in the California Teachers Study. All sites of invasive cancer prospectively diagnosed from baseline (1995–1996) through 2011 were identified through linkage to the California Cancer Registry (n = 12,322). Site-specific analyses focused on the following cancers: breast (n = 5,053), colorectal (n = 983), lung (n = 820), melanoma (n = 749), and endometrial (n = 957). Additionally, we evaluated a group of estrogen-mediated cancers consisting of breast, endometrial, and ovarian cancer (n = 6,458). Sleep duration was based on self-report of average time sleeping in the year prior to baseline. Cox proportional hazard models were used to calculate adjusted hazard ratios and 95 % confidence intervals (HRs, 95 % CI).

Results

Point estimates for all sites and site-specific cancers generally were near or below one for short sleepers (<6 h/night) and above one for long sleepers (10+ h/night); confidence intervals, however, were wide and included unity. Compared to average sleepers (7–9 h/night), long sleepers had an increased risk of the group of estrogen-mediated cancers (HR 1.22, 95 % CI 0.97–1.54, p (trend) = 0.04).

Conclusions

These analyses suggest that longer sleep may be associated with increased risks of estrogen-mediated cancers. Further studies with more refined measures of sleep duration and quality are warranted.
Literatur
3.
Zurück zum Zitat Institute of Medicine (2006) Sleep disorders and sleep deprivation: an unmet public health problem. The National Academies Press, Washington Institute of Medicine (2006) Sleep disorders and sleep deprivation: an unmet public health problem. The National Academies Press, Washington
5.
6.
Zurück zum Zitat Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG (2010) The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep 33(6):739–744PubMedCentralPubMed Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG (2010) The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep 33(6):739–744PubMedCentralPubMed
7.
Zurück zum Zitat Heianza Y, Kato K, Fujihara K, Tanaka S, Kodama S, Hanyu O, Sato K, Sone H (2014) Role of sleep duration as a risk factor for Type 2 diabetes among adults of different ages in Japan: the Niigata Wellness Study. Diabet Med. doi:10.1111/dme.12555 Heianza Y, Kato K, Fujihara K, Tanaka S, Kodama S, Hanyu O, Sato K, Sone H (2014) Role of sleep duration as a risk factor for Type 2 diabetes among adults of different ages in Japan: the Niigata Wellness Study. Diabet Med. doi:10.​1111/​dme.​12555
8.
Zurück zum Zitat Lehrer S, Green S, Ramanathan L, Rosenzweig KE (2013) Obesity and deranged sleep are independently associated with increased cancer mortality in 50 US states and the District of Columbia. Sleep Breath 17(3):1117–1118. doi:10.1007/s11325-013-0811-x PubMedCrossRef Lehrer S, Green S, Ramanathan L, Rosenzweig KE (2013) Obesity and deranged sleep are independently associated with increased cancer mortality in 50 US states and the District of Columbia. Sleep Breath 17(3):1117–1118. doi:10.​1007/​s11325-013-0811-x PubMedCrossRef
12.
Zurück zum Zitat Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A (2009) Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32(4):491–497PubMedCentralPubMed Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A (2009) Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32(4):491–497PubMedCentralPubMed
13.
Zurück zum Zitat Zhao H, Yin JY, Yang WS, Qin Q, Li TT, Shi Y, Deng Q, Wei S, Liu L, Wang X, Nie SF (2013) Sleep duration and cancer risk: a systematic review and meta-analysis of prospective studies. Asian Pac J Cancer Prev 14(12):7509–7515PubMedCrossRef Zhao H, Yin JY, Yang WS, Qin Q, Li TT, Shi Y, Deng Q, Wei S, Liu L, Wang X, Nie SF (2013) Sleep duration and cancer risk: a systematic review and meta-analysis of prospective studies. Asian Pac J Cancer Prev 14(12):7509–7515PubMedCrossRef
15.
Zurück zum Zitat Girschik J, Heyworth J, Fritschi L (2013) Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case–control study. Am J Epidemiol 177(4):316–327. doi:10.1093/aje/kws422 PubMedCrossRef Girschik J, Heyworth J, Fritschi L (2013) Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case–control study. Am J Epidemiol 177(4):316–327. doi:10.​1093/​aje/​kws422 PubMedCrossRef
16.
Zurück zum Zitat Hu LY, Chen PM, Hu YW, Shen CC, Perng CL, Su TP, Yen SH, Tzeng CH, Chiou TJ, Yeh CM, Chen TJ, Wang WS, Liu CJ (2013) The risk of cancer among patients with sleep disturbance: a nationwide retrospective study in Taiwan. Ann Epidemiol 23(12):757–761PubMedCrossRef Hu LY, Chen PM, Hu YW, Shen CC, Perng CL, Su TP, Yen SH, Tzeng CH, Chiou TJ, Yeh CM, Chen TJ, Wang WS, Liu CJ (2013) The risk of cancer among patients with sleep disturbance: a nationwide retrospective study in Taiwan. Ann Epidemiol 23(12):757–761PubMedCrossRef
22.
Zurück zum Zitat McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM (2006) Duration of sleep and breast cancer risk in a large population-based case–control study. J Sleep Res 15(3):241–249PubMedCrossRef McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM (2006) Duration of sleep and breast cancer risk in a large population-based case–control study. J Sleep Res 15(3):241–249PubMedCrossRef
23.
Zurück zum Zitat Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66(10):5521–5525PubMedCrossRef Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66(10):5521–5525PubMedCrossRef
25.
Zurück zum Zitat Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65(20):9595–9600PubMedCrossRef Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65(20):9595–9600PubMedCrossRef
26.
Zurück zum Zitat Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, Endeshaw Y, Lewis CE, Manson JE, Chlebowski RT (2013) Association between sleep and breast cancer incidence among postmenopausal women in the Women’s Health Initiative. Sleep 36(10):1437–1444. doi:10.5665/sleep.3032 PubMedCentralPubMed Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, Endeshaw Y, Lewis CE, Manson JE, Chlebowski RT (2013) Association between sleep and breast cancer incidence among postmenopausal women in the Women’s Health Initiative. Sleep 36(10):1437–1444. doi:10.​5665/​sleep.​3032 PubMedCentralPubMed
27.
Zurück zum Zitat von Ruesten A, Weikert C, Fietze I, Boeing H (2012) Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS ONE 7(1):e30972. doi:10.1371/journal.pone.0030972 CrossRef von Ruesten A, Weikert C, Fietze I, Boeing H (2012) Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS ONE 7(1):e30972. doi:10.​1371/​journal.​pone.​0030972 CrossRef
28.
Zurück zum Zitat Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan—results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40(1):21–30. doi:10.3892/ijo.2011.1194 PubMed Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan—results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40(1):21–30. doi:10.​3892/​ijo.​2011.​1194 PubMed
30.
Zurück zum Zitat Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29(6):1244–1248PubMedCentralPubMedCrossRef Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29(6):1244–1248PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J (2013) Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 36(5):681–688. doi:10.5665/sleep.2626 PubMedCentralPubMed Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, Schernhammer ES, Fuchs CS, Redline S, Willett WC, Ma J (2013) Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 36(5):681–688. doi:10.​5665/​sleep.​2626 PubMedCentralPubMed
32.
33.
Zurück zum Zitat Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13(7):625–635PubMedCrossRef Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13(7):625–635PubMedCrossRef
35.
Zurück zum Zitat Hurley S, Nelson DO, Garcia E, Gunier R, Hertz A, Reynolds P (2013) A cross-sectional analysis of light at night, neighborhood sociodemographics and urinary 6-sulfatoxymelatonin concentrations: implications for the conduct of health studies. Int J Health Geogr 12:39. doi:10.1186/1476-072X-12-39 PubMedCentralPubMedCrossRef Hurley S, Nelson DO, Garcia E, Gunier R, Hertz A, Reynolds P (2013) A cross-sectional analysis of light at night, neighborhood sociodemographics and urinary 6-sulfatoxymelatonin concentrations: implications for the conduct of health studies. Int J Health Geogr 12:39. doi:10.​1186/​1476-072X-12-39 PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Reynolds P, Hurley SE, Quach AT, Rosen H, Von Behren J, Hertz A, Smith D (2005) Regional variations in breast cancer incidence among California women, 1988–1997. Cancer Causes Control 16(2):139–150. doi:10.1007/s10552-004-2616-5 PubMedCrossRef Reynolds P, Hurley SE, Quach AT, Rosen H, Von Behren J, Hertz A, Smith D (2005) Regional variations in breast cancer incidence among California women, 1988–1997. Cancer Causes Control 16(2):139–150. doi:10.​1007/​s10552-004-2616-5 PubMedCrossRef
38.
Zurück zum Zitat Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB (2004) A prospective study of sleep duration and mortality risk in women. Sleep 27(3):440–444PubMed Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB (2004) A prospective study of sleep duration and mortality risk in women. Sleep 27(3):440–444PubMed
40.
Zurück zum Zitat Stevens RG (2009) Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world. Mutat Res 679(1–2):6–8 Stevens RG (2009) Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world. Mutat Res 679(1–2):6–8
41.
Zurück zum Zitat Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26(2):380–384PubMedCrossRef Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26(2):380–384PubMedCrossRef
42.
Zurück zum Zitat Nock NL, Li L, Larkin EK, Patel SR, Redline S (2009) Empirical evidence for “syndrome Z”: a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep 32(5):615–622PubMedCentralPubMed Nock NL, Li L, Larkin EK, Patel SR, Redline S (2009) Empirical evidence for “syndrome Z”: a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep 32(5):615–622PubMedCentralPubMed
43.
Zurück zum Zitat Patel SR, Blackwell T, Redline S, Ancoli-Israel S, Cauley JA, Hillier TA, Lewis CE, Orwoll ES, Stefanick ML, Taylor BC, Yaffe K, Stone KL (2008) The association between sleep duration and obesity in older adults. Int J Obes (Lond) 32(12):1825–1834. doi:10.1038/ijo.2008.198 PubMedCentralCrossRef Patel SR, Blackwell T, Redline S, Ancoli-Israel S, Cauley JA, Hillier TA, Lewis CE, Orwoll ES, Stefanick ML, Taylor BC, Yaffe K, Stone KL (2008) The association between sleep duration and obesity in older adults. Int J Obes (Lond) 32(12):1825–1834. doi:10.​1038/​ijo.​2008.​198 PubMedCentralCrossRef
44.
45.
Zurück zum Zitat Anisimov VN (2003) The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 46(3):221–234PubMedCrossRef Anisimov VN (2003) The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 46(3):221–234PubMedCrossRef
46.
Metadaten
Titel
Sleep duration and cancer risk in women
verfasst von
Susan Hurley
Debbie Goldberg
Leslie Bernstein
Peggy Reynolds
Publikationsdatum
01.07.2015
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 7/2015
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0579-3

Weitere Artikel der Ausgabe 7/2015

Cancer Causes & Control 7/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.